March6 Protects Against Acute Kidney Injury by Suppressing Renal Tubular Epithelial Cell Ferroptosis Through the Destabilization of P53 and ACSL4 Proteins

Acute kidney injury (AKI) progression involves significant contributions from renal tubular epithelial cell ferroptosis. Membrane associated RING finger protein 6 (March6) is implicated in modulating ferroptosis by regulating the stability of related proteins, yet its specific role in tubular epithelial cell ferroptosis and AKI progression remains unknown. This work seeks to clarify the regulatory role of March6 in the ferroptosis of tubular epithelial cells and its involvement in AKI using ischemia-reperfusion injury (IRI)-induced animal models and hypoxia/reoxygenation (H/R)-induced cellular models. Our results demonstrated a significant reduction in March6 expression in renal tissues from IRI mice and H/R cells, accompanied by elevated PTGS2 and reduced GPX4 levels, two ferroptosis marker proteins. Overexpression of March6 in HK-2 cells significantly counteracted Erastin-induced ferroptosis, whereas silencing March6 increased susceptibility. In H/R models, March6 overexpression enhanced cell viability and lowered cell death, reversing ferroptosis-related changes, whereas silencing March6 exhibited the opposite effects. Tubular-specific overexpression of March6 in mice with IRI-induced AKI notably mitigated kidney damage and suppressed ferroptotic changes. Mechanistically, March6 inhibited ferroptosis by accelerating the degradation of key pro-ferroptotic proteins ACSL4 and p53. Co-immunoprecipitation (Co-IP) experiments validated the direct interaction between March6 and p53 or ACSL4. Overexpressing ACSL4 or p53 in March6-overexpressing HK-2 cells markedly reversed March6's protective effects against H/R-induced damage and ferroptosis. Collectively, March6 mitigates ferroptosis in renal tubular epithelial cells by promoting the degradation of ACSL4 and p53, thereby alleviating AKI progression. This study not only uncovers a novel regulatory mechanism of tubular epithelial cell ferroptosis in AKI but also provides a potential therapeutic target for its treatment.

Authors

Institutions

Publication Details

Journal
Inflammation
Published
2025-05-29
DOI
https://doi.org/10.1007/s10753-025-02319-z
Citations
2
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
2.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

March6 Protects Against Acute Kidney Injury by Suppressing Renal Tubular Epithelial Cell Ferroptosis Through the Destabilization of P53 and ACSL4 Proteins

Liyi Xie, Yurui Guo, Ranran Kong, Yi Yang et al.
2 citations
Inflammation
Chronic Kidney Disease and Diabetes
2.86
article

March6 Protects Against Acute Kidney Injury by Suppressing Renal Tubular Epithelial Cell Ferroptosis Through the Destabilization of P53 and ACSL4 Proteins

Liyi Xie, Yurui Guo, Ranran Kong, Yi Yang, Jie Feng, Hongjuan Dong
article en
2 citations

Abstract

Acute kidney injury (AKI) progression involves significant contributions from renal tubular epithelial cell ferroptosis. Membrane associated RING finger protein 6 (March6) is implicated in modulating ferroptosis by regulating the stability of related proteins, yet its specific role in tubular epithelial cell ferroptosis and AKI progression remains unknown. This work seeks to clarify the regulatory role of March6 in the ferroptosis of tubular epithelial cells and its involvement in AKI using ischemia-reperfusion injury (IRI)-induced animal models and hypoxia/reoxygenation (H/R)-induced cellular models. Our results demonstrated a significant reduction in March6 expression in renal tissues from IRI mice and H/R cells, accompanied by elevated PTGS2 and reduced GPX4 levels, two ferroptosis marker proteins. Overexpression of March6 in HK-2 cells significantly counteracted Erastin-induced ferroptosis, whereas silencing March6 increased susceptibility. In H/R models, March6 overexpression enhanced cell viability and lowered cell death, reversing ferroptosis-related changes, whereas silencing March6 exhibited the opposite effects. Tubular-specific overexpression of March6 in mice with IRI-induced AKI notably mitigated kidney damage and suppressed ferroptotic changes. Mechanistically, March6 inhibited ferroptosis by accelerating the degradation of key pro-ferroptotic proteins ACSL4 and p53. Co-immunoprecipitation (Co-IP) experiments validated the direct interaction between March6 and p53 or ACSL4. Overexpressing ACSL4 or p53 in March6-overexpressing HK-2 cells markedly reversed March6's protective effects against H/R-induced damage and ferroptosis. Collectively, March6 mitigates ferroptosis in renal tubular epithelial cells by promoting the degradation of ACSL4 and p53, thereby alleviating AKI progression. This study not only uncovers a novel regulatory mechanism of tubular epithelial cell ferroptosis in AKI but also provides a potential therapeutic target for its treatment.

InflammationVol. 48(6)
First Affiliated Hospital of Xi'an Jiaotong University (CN), Second Affiliated Hospital of Xi'an Jiaotong University (CN)
National Natural Science Foundation of China, Wu Jieping Medical Foundation, Natural Science Basic Research Program of Shaanxi Province
Good health and well-being
Openalex Percentile: Top 10%
Chronic Kidney Disease and Diabetes
2.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.